The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global oncology injectables market exhibited strong growth during 2014-2019. Oncology injectables refer to the intravenous drugs that are infused in the body during cancer treatment. These injectables mitigate the growth of cancer-inducing proteins along with killing the malignant cells in the body. Injectable oncology drugs offer enhanced efficacy, increased bioavailability, reduced gastrointestinal irritation, and better compliance. As a result, oncology injectables are widely used for treating various types of cancers.
The rising prevalence of cancer across the globe coupled with the growing awareness towards its early detection is primarily catalysing the demand for oncology injectables. Moreover, several pharmaceutical and biotechnology companies are heavily investing in the development of new anti-cancer intravenous drugs with minimal side effects and target-oriented attack. Across the developed world, the wide presence of advanced medical infrastructure along with the easy accessibility to chemotherapy treatments is further proliferating the market for oncology injectables. Additionally, faster drug approvals from various regulatory bodies, such as the U.S. Food and Drug Administration (FDA), have created a positive impact on the market growth. In emerging economies, factors such as rising healthcare expenditures, increasing penetration of healthcare insurance and improving healthcare infrastructure are propelling the market for oncology injectables. Furthermore, various blockbuster branded oncology injectables are expected to become off-patent in the next few years. This is expected to create huge opportunities for generics and biosimilar manufacturers. Looking forward, IMARC Group expects the global oncology injectables market to continue its strong growth during the next five years.
Breakup by Molecule Type:
Breakup by Product Type:
Breakup by Indication:
Breakup by Branded/Generics:
Breakup by Distribution Channel:
Breakup by Region:
The report has also analysed the competitive landscape of the market along with the profiles of the key players.
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at